|
|
|
|
Report No. : |
510840 |
|
Report Date : |
26.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
KAWAMOTO CORPORATION |
|
|
|
|
Registered Office : |
Tanimachi Bldg 2-6-4 Tanimachi Chuoku Osaka 540-0012 JAPAN |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.03.2018 |
|
|
|
|
Date of Incorporation : |
Jan 1931 |
|
|
|
|
Com. Reg. No.: |
1200-01-077174 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Manufactures medical products (38%), sales to consumers |
|
|
|
|
No. of Employees : |
291 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Maximum Credit Limit : |
Yen 1,061.4 Million |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
JAPAN - ECONOMIC OVERVIEW
Over the past 70 years, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (slightly less than 1% of GDP) have helped Japan develop an advanced economy. Two notable characteristics of the post-World War II economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features have significantly eroded under the dual pressures of global competition and domestic demographic change.
Measured on a purchasing power parity basis that adjusts for price differences, Japan in 2017 stood as the fourth-largest economy in the world after first-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. For three postwar decades, overall real economic growth was impressive - averaging 10% in the 1960s, 5% in the 1970s, and 4% in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the aftereffects of inefficient investment and the collapse of an asset price bubble in the late 1980s, which resulted in several years of economic stagnation as firms sought to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession four times since 2008.
Japan enjoyed an uptick in growth since 2013, supported by Prime Minister Shinzo ABE’s “Three Arrows” economic revitalization agenda - dubbed “Abenomics” - of monetary easing, “flexible” fiscal policy, and structural reform. Led by the Bank of Japan’s aggressive monetary easing, Japan is making modest progress in ending deflation, but demographic decline – a low birthrate and an aging, shrinking population – poses a major long-term challenge for the economy. The government currently faces the quandary of balancing its efforts to stimulate growth and institute economic reforms with the need to address its sizable public debt, which stands at 235% of GDP. To help raise government revenue, Japan adopted legislation in 2012 to gradually raise the consumption tax rate. However, the first such increase, in April 2014, led to a sharp contraction, so Prime Minister ABE has twice postponed the next increase, which is now scheduled for October 2019. Structural reforms to unlock productivity are seen as central to strengthening the economy in the long-run.
Scarce in critical natural resources, Japan has long been dependent on imported energy and raw materials. After the complete shutdown of Japan’s nuclear reactors following the earthquake and tsunami disaster in 2011, Japan's industrial sector has become even more dependent than before on imported fossil fuels. However, ABE’s government is seeking to restart nuclear power plants that meet strict new safety standards and is emphasizing nuclear energy’s importance as a base-load electricity source. In August 2015, Japan successfully restarted one nuclear reactor at the Sendai Nuclear Power Plant in Kagoshima prefecture, and several other reactors around the country have since resumed operations; however, opposition from local governments has delayed several more restarts that remain pending. Reforms of the electricity and gas sectors, including full liberalization of Japan’s energy market in April 2016 and gas market in April 2017, constitute an important part of Prime Minister Abe’s economic program.
Under the Abe Administration, Japan’s government sought to open the country’s economy to greater foreign competition and create new export opportunities for Japanese businesses, including by joining 11 trading partners in the Trans-Pacific Partnership (TPP). Japan became the first country to ratify the TPP in December 2016, but the United States signaled its withdrawal from the agreement in January 2017. In November 2017 the remaining 11 countries agreed on the core elements of a modified agreement, which they renamed the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). Japan also reached agreement with the European Union on an Economic Partnership Agreement in July 2017, and is likely seek to ratify both agreements in the Diet this year.
|
Source
: CIA |
KAWAMOTO
CORPORATION
REGD
NAME: Kawamoto Sangyo KK
MAIN
OFFICE: Tanimachi Bldg 2-6-4
Tanimachi Chuoku Osaka 540-0012 JAPAN
Tel:
06-6943-8951 Fax: 06-6943-7951 -
URL: http://www.kawamoto-sangyo.co.jp
E-Mail address: (thru
the URL)
ACTIVITIES: Mfg of medical sanitary materials, such as
gauze, cotton wool & bandage, others
BRANCHES: Tokyo, Nagoya, Hiroshima, Fukuoka
OVERSEAS: Worldwide
FACTORIES: Osaka
OFFICERS: TAKESHI KAWAMOTO, PRES Makoto Fukui, s/mgn dir
Hiroshi
Mizukami, mgn dir Tetsuya Ozawa,
dir
Tohru
Minabune, dir Toshihiko
Kusakami, dir
Yen Amount: In
million Yen, unless otherwise stated
FINANCES FAIR A/SALES Yen 23,257 M
PAYMENTS REGULAR CAPITAL Yen
883 M
TREND UP WORTH Yen 8,601 M
STARTED 1931 EMPLOYES 291
MFR OF MEDICAL SANITARY MATERIALS, OTHER
FINANCIAL SITUATION COSIDERED FAIR AND GOOD FOR ORDINARY
BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT: YEN 1,061.4 MILLION, 30 DAYS NORMAL TERMS
This is the largest mfr & supplier of medical sanitary
materials, including gauze, cotton wool & bandages. Founded in 1914, and customers number around
2,500 firms. Also engaged in the mfg
& sale of medical goods including masks & surgical gowns as well as
nursing care goods such as oral care sponges.
Became a subsidiary of AIR WATER INC through a TOB in December 2016.
The sales volume for Mar/2018 fiscal term amounted to Yen
23,257 million, a 1.16% up from Yen 22,990 million in the previous term. The recurring profit was posted at Yen 132 million
and the net profit at Yen 147 million, respectively, compared with Yen 33
million recurring profit and Yen 92 million net profit, respectively, a year
ago.
For the
current term ending Mar 2019 the recurring profit is projected at Yen 170
million and the net profit at Yen 150 million, respectively, on an 8.35% rise
in turnover, to Yen 25,200 million.
The financial situation is considered FAIR and good for
ORDINARY business engagements. Max
credit limit is estimated at Yen 1,061.4 million, on 30 days normal terms.
Date
Registered: Jan 1931
Regd
No.: 1200-01-077174
(Osaka-Chuoku)
Listed
company: Tokyo (Second
Section)
Legal
Status: Limited Company (Kabushiki Kaisha)
Authorized: 16 million shares
Issued:
6,000,000 shares
Sum: Yen 883 million
Major
shareholders (%): Air Water (48.3), Takeshi Kawamoto (4.9), TK Co (4.9),
MSJP Client Securities (4.3), Company’s Treasury Stock (3.4), Fumio Mori (1.0),
Sompo Japan Nipponkoa Ins (0.8), Resona Bank (0.7), Yonosuke Kawamoto (0.6),
Japan Trustee Services T (0.6); foreign owners (4.5)
No. of
shareholders: 1,284
Nothing detrimental is known as to the commercial morality
of executives.
Activities:
Manufactures medical products (38%), sales to consumers (62%)
Clients: [Mfrs, wholesalers] Nishimatsuya Chains
(36.3%), Astem Corp, TS Alfresa, Shimamaura Co, Home Idan & Kho Waiter,
other
No. of accounts: 800
Domestic areas of activities: Nationwide
Suppliers:
[Mfrs, wholesalers] Vision Inc, Uny Cham Corp, Marusan Sangyo, Ozu Sangyo, Snow
Brands, Health Care Inc, Nichiban Inc, other
Payment
record: Regular
Location:
Business area in Osaka. Office premises
at the caption address are leased and maintained satisfactorily.
Bank
References:
Mizuho Bank (Semba)
MUFG (Kawaramachi)
Relations: Satisfactory
(In
Million Yen)
|
Terms Ending: |
31/03/2019 |
31/03/2018 |
31/03/2017 |
31/03/2016 |
|
|
Annual Sales |
|
25,200 |
23,257 |
22,990 |
26,765 |
|
Recur. Profit |
|
170 |
132 |
33 |
23 |
|
Net Profit |
|
150 |
147 |
92 |
-503 |
|
Total Assets |
|
|
14,345 |
13,940 |
16,847 |
|
Current Assets |
|
|
11,096 |
11,742 |
14,699 |
|
Current Liabs |
|
|
8,161 |
6,090 |
7,605 |
|
Net Worth |
|
|
8,601 |
2,088 |
2,140 |
|
Capital, Paid-Up |
|
|
883 |
883 |
883 |
|
Div.P.Share(¥) |
|
|
2.00 |
2.00 |
0.00 |
|
<Analytical Data> |
|
(%) |
(%) |
(%) |
(%) |
|
S.Growth Rate |
|
8.35 |
1.16 |
-14.10 |
-5.91 |
|
Current Ratio |
|
.. |
135.96 |
192.81 |
193.28 |
|
N.Worth Ratio |
|
.. |
59.96 |
14.98 |
12.70 |
|
R.Profit/Sales |
|
0.67 |
0.57 |
0.14 |
0.09 |
|
N.Profit/Sales |
|
0.60 |
0.63 |
0.40 |
-1.88 |
|
Return On Equity |
|
.. |
1.71 |
4.41 |
-23.50 |
Notes: Forecast (or estimated) figures for the 31/03/2019
fiscal term
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 68.26 |
|
|
1 |
INR 91.22 |
|
Euro |
1 |
INR 79.88 |
|
YEN |
1 |
INR 0.62 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
VIV |
|
|
|
|
Report Prepared
by : |
KET |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.